[1]
|
Ferlay, J., Shin, H.R., Bray, F., Forman, D., Mathers, C. and Parkin, D.M. (2010) Estimates of Worldwide Burden of Caner in 2008: GLOBOCAN 2008. International Journal of Cancer, 127, 2893-2917.
|
[2]
|
(2014) Hong Kong Cancer Registry, “Hong Kong Cancer Statistics 2014”. Hong Kong Hospital Authority, Hong Kong.
https://www3.ha.org.hk/cancereg/pdf/overview/Summary%20of%20CanStat%202014.pdf
|
[3]
|
Wang, X.S., Di, L.J., Reyes-Gibby, C.C., Guo, H., Liu, S.J. and Gleeland, C.S. (2004) End-of-Life Care in Urban Areas of China: A Survey of 60 Oncology Clinicians. Journal of Pain and Symptom Management, 27, 125-132.
https://doi.org/10.1016/j.jpainsymman.2003.06.002
|
[4]
|
Chen, K., Wang, P.P., Sun, B., Li, Q., Perruccio, A., Power, D., et al. (2006) Twenty-Year Secular Changes in Sex Specific Lung Cancer Incidence Rates in an Urban Chinese Population. Lung Cancer, 51, 13-19.
https://doi.org/10.1016/j.lungcan.2005.08.013
|
[5]
|
Andre, N. (2012) Metronomic Chemotherapy in Pediatric Oncology: A Way for Low-Income Countries? Metronomics Global Health Initiative.
http://metronomics.newethicalbusiness.org/Metronomic-Chemotherapy-in,184
|
[6]
|
Ernst, E. and Cassileth, B.R. (1998) The Prevalence of Complementary/Alternative Medicine in Cancer: A Systematic Review. Cancer, 83, 777-782.
https://doi.org/10.1002/(SICI)1097-0142(19980815)83:4<777::AID-CNCR22>3.0.CO;2-O
|
[7]
|
Huebner, J., Prott, F.J., Micke, O., Muecke, R., Senf, B., Dennert, G., et al. (2014) Online Survey of Cancer Patients on Complementary and Alternative Medicine. Oncology Research and Treatment, 37, 304-308. https://doi.org/10.1159/000362616
|
[8]
|
Deng, G. and Cassileth, B.R. (2005) Integrative Oncology: Complementary Therapies for Pain, Anxiety, and Mood Disturbance. CA: A Cancer Journal for Clinicians, 55, 109-116. https://doi.org/10.3322/canjclin.55.2.109
|
[9]
|
Wong, T.W., Wong, S.L. and Sturat, P.B.D. (1993) Traditional Chinese Medicine and Western Medicine in Hong Kong: A Comparison of the Consultation Processes and Side Effects. Journal of Hong Kong Medical Association, 45, 278-284.
|
[10]
|
Luo, J. and Chu, D.T. (2002) Evaluation of the Quality of Life in the Treatment of Malignant Tumor. Chinese Journal of Oncology, 24, 411-413.
|
[11]
|
Schipper, H., Clinch, J., McMurray, A. and Levitt, M. (1984) Measuring the Quality of Life of Cancer Patients: The Functional Living Index-Cancer: Development and Validation. Journal of Clinical Oncology, 2, 472-483.
|
[12]
|
Mok, T.S.K., Yeo, W., Johnson, P.J., Hui, P., Ho, W.M., Lam, K.C., et al. (2007) A Double-Blind Placebo-Controlled Randomized Study of Chinese Herbal Medicine as Complementary Therapy for Reduction of Chemotherapy-Induced Toxicity. Annals of Oncology, 18, 768-774. https://doi.org/10.1093/annonc/mdl465
|
[13]
|
Bao, Y.X., Wong, C.K., Leung, S.F., Chan, A.T., Li, P.W., Wong, E.L., et al. (2006) Clinical Studies of Immunomodulatory Activities of Yunzhi-Danshen in Patients with Nasopharyngeal Carcinoma. Journal of Alternative and Complementary Medicine, 12, 771-776. https://doi.org/10.1089/acm.2006.12.771
|
[14]
|
Wong, C.K., Bao, Y.X., Wong, E.L., Leung, P.C., Fung, K.P. and Lam, C.W. (2005) Immunomodulatory Activities of Yunzhi and Danshen in Post-Treatment Breast Cancer Patients. The American Journal of Chinese Medicine, 33, 381-395.
https://doi.org/10.1142/S0192415X05002990
|
[15]
|
Wong, C.K., Tse, P.S., Wong, E.L., Leung, P.C., Fung, K.P. and Lam, C.W. (2004) Immunomodulatory Effects of Yunzhi and Danshen Capsules in Health Subjects—A Randomized, Double-Blind, Placebo-Controlled, Crossover Study. International Immunopharmacology, 4, 201-211.
https://doi.org/10.1016/j.intimp.2003.12.003
|
[16]
|
Leung, P.C., Ooi, V., Wong, E.L.Y., Au, W.C., Wong, C.K., Lam, W.K., et al. (2007) Chinese Medicine and Cancer Treatment in Hong Kong. A General Review. Asia Pacific Biotech News, 11, 1108-1112.
http://www.asiabiotech.com/publication/apbn/11/english/preserved-docs/1116/1108_1113.pdf
https://doi.org/10.1142/9789812709301_0003
|
[17]
|
Nikkei Medical Group (2007) Utilization Survey of Kampo Medicines. Vol. 10, 41-47.
|
[18]
|
Kono, T., Kanematsu, T. and Kitajima, M. (2009) Exodus of Kampo, Traditional Japanese Medicine, from the Complementary and Alternative Medicine: Is It Time Yet? Surgery, 146, 837-840. https://doi.org/10.1016/j.surg.2009.06.012
|
[19]
|
Zhang, Q.H. and Leung, P.C. (2015) Practice and Research on Chinese Medicine Outside of China. In: Leung, P.C. Ed., A Comprehensive Guide to Chinese Medicine, World Scientific Publisher, Singapore, 209-238.
https://doi.org/10.1142/9789814667081_0008
|
[20]
|
Kummar, S., Copur, M.S., Rose, M., Wadler, S., Stephenson, J., O’Rourke, M., et al. (2011) A Phase I Study of the Chinese Herbal Medicine PHY906 as a Modulator of Irinotecan-Based Chemotherapy in Patients with Advanced Colorectal Cancer. Clinical Colorectal Cancer, 10, 85-96. https://doi.org/10.1016/j.clcc.2011.03.003
|
[21]
|
Lau, C.B.S., Yue, G.G.L., Fung, K.P., Tan, N.H. and Leung, P.C. (2015) The Potential Role of Chinese Herbal Medicines in Cancer Management. Science, 347, S45-S47.
|
[22]
|
Chung, H.L., Yue, G.G.L., To, K.F., Su, Y.L., Huang, Y. and Ko, W.H. (2007) Effect of Scutellariae Radix Extract on Experimental Dextran-Sulfate Sodium-Induced Colitis in Rats. World Journal of Gastroenterology, 13, 5605-5611.
|
[23]
|
Yue, G.G.L., Lee, J.K.M., Kowk, H.F., Cheng, L., Wong, E.C.W., Jiang, L., et al. (2015) Novel PI3K/AKT Targeting Anti-Angiogenic Activities of 4-Vinylphenol, a New Therapeutic Potential of a Well-Known Styrene Metabolite. Scientific Reports, 5, Article No. 11149. https://doi.org/10.1038/srep11149
|
[24]
|
Hibasami, H., Fujikawa, T., Takeda, H., Nishibe, S., Satoh, T., Fujisawa, T., et al. (2000) Induction of Apoptosis by Acanthopanax senticosus HARMS and Its Component, Sesamin in Human Stomach Cancer KATO III Cells. Oncology Reports, 7, 1213-1216.
|
[25]
|
Yue, G.G., Fung, K.P., Tse, G.M., Leung, P.C. and Lau, C.B. (2006) Comparative Studies of Various Ganoderma Species and Their Different Parts with Regards to Their Antitumor and Immunomodulating Activities in Vitro. Journal of Alternative and Complementary Medicine, 12, 777-789.
https://doi.org/10.1089/acm.2006.12.777
|
[26]
|
Yue, G.G., Fung, K.P., Leung, P.C. and Lau, C.B. (2008) Comparative Studies on the Immunomodulatory and Antitumor Activities of the Different Parts of Fruiting Body of Ganoderma lucidum and Ganoderma Spores. Phytotherapy Research, 22, 1282-1291. https://doi.org/10.1002/ptr.2478
|
[27]
|
Han, X.Q., Yue, G.L., Yue, R.Q., Dong, C.X., Chan, C.L., Ko, C.H., et al. (2014) Structure Elucidation and Immunomodulatory Activities of a Beta Glucan from the Fruiting Bodies of Ganoderma sinense. PLoS ONE, 9, e100380.
https://doi.org/10.1371/journal.pone.0100380
|
[28]
|
Yue, G.G.L., Lee, J.K.M., Li, L., Chan, K.M., Wong, E.C.W., Chan, J.Y.W., et al. (2015) Andrographis paniculata Elicits Anti-Invasion Activities by Suppressing TM4SF3 Gene Expression and by Anoikis-Sensitization in Esophageal Cancer Cells. American Journal of Cancer Research, 5, 3570-3587.
|
[29]
|
Meropol, N.J., Schrag, D., Smith, T.J., Mulvey, T.M., Langdon, R.M., Blum, D., et al. (2009) American Society of Clinical Oncology Guidance Statement: The Cost of Cancer Care. Journal of Clinical Oncology, 27, 3868-3874.
https://doi.org/10.1200/JCO.2009.23.1183
|
[30]
|
Hanahan, D., Bergers, G. and Bergsland, E. (2000) Less Is More, Regularly: Metronomic Dosing of Cytotoxic Drugs Can Target Tumor Angiogenesis in Mice. Journal of Clinical Investigation, 108, 1045-1047. https://doi.org/10.1172/JCI9872
|
[31]
|
Goss, P.E., Strasser-Weippl, K., Lee-Bychkovsky, B.L., Fan, L., Li, J., Chavarri-Guerra, Y., et al. (2014) Challenges to Effective Cancer Control in China, India and Russia. The Lancet Oncology, 15, 489-538.
https://doi.org/10.1016/S1470-2045(14)70029-4
|
[32]
|
Andre, N., Banavali, S., Snihur, Y. and Pasquier, E. (2013) Has the Time Come for Metronomics in Low-Income and Middle-Income Countries? The Lancet Oncology, 14, e239-e248.
|
[33]
|
Kerbel, R.S. and Kamen, B.A. (2004) The Anti-Angiogenic Basic of Metronomic Chemotherapy. Nature Reviews Cancer, 4, 423-436. https://doi.org/10.1038/nrc1369
|
[34]
|
Shaked, Y., Emmenegger, U., Man, S., Cervi, D., Bertolini, F., Ben-David, Y., et al. (2005) Optimal Biologic Dose of Metronomic Chemotherapy Regimens Is Associated with Maximum Anti-Angiogenic Activity. Blood, 106, 3058-3061.
https://doi.org/10.1182/blood-2005-04-1422
|
[35]
|
Scharovsky, O.G., Mainetti, L.E. and Rozados, V.R. (2009) Metronomic Chemotherapy: Changing the Paradigm That More Is Better. Current Oncology, 16, 7-15.
https://doi.org/10.3747/co.v16i2.420
|
[36]
|
Maiti, R. (2014) Metronomic Chemotherapy. Journal of Pharmacology and Pharmacotherapeutics, 5, 186-192. https://doi.org/10.4103/0976-500X.136098
|
[37]
|
Mross, K. and Steinbild, S. (2012) Metronomic Anti-Cancer Therapy—An Ongoing Treatment Option for Advanced Cancer Patients. Journal of Cancer Therapeutics and Research, 1, 32. https://doi.org/10.7243/2049-7962-1-32
|
[38]
|
Collova, E., Sebastiani, F., De Matteis, E., Generali, D., Aurillio, G., Boccardo, F., et al. (2011) Use of Metronomic Chemotherapy in Oncology: Results from a National Italian Survey. Tumori Journal, 97, 454-458.
|
[39]
|
Bocci, G., Tuccori, M., Emmenegger, U., Liquori, V., Falcone, A., Kerbel, R.S., et al. (2005) Cyclophosphamide-Methotrexate Metronomic Chemotherapy for the Palliative Treatment of Metastatic Breast Cancer. A Comparative Pharmacoeconomic Evaluation. Annals of Oncology, 16, 1243-1252.
https://doi.org/10.1093/annonc/mdi240
|
[40]
|
Kato, H., Ichinose, Y., Ohta, M., Hata, E., Tsubota, N., Tada, H., et al. (2004) A Randomized Trial of Adjuvant Chemotherapy with Uracil-Tegafur for Adenocarcinoma of the Lung. The New England Journal of Medicine, 350, 1713-1721.
https://doi.org/10.1056/NEJMoa032792
|
[41]
|
Martin-Padura, I., Marighetti, P., Agliano, A., Colombo, F., Larzabal, L., Redrado, M., et al. (2012) Residual Dormant Cancer Stem-Cell Foci Are Responsible for Tumor Relapse after Antiangiogenic Metronomic Therapy in Hepatocellular Carcinoma Xenografts. Laboratory Investigation, 92, 952-966.
https://doi.org/10.1038/labinvest.2012.65
|
[42]
|
Emmenegger, U., Francia, G., Shaked, Y. and Kerbel, R.S. (2010) Metronomic Chemotherapy: Principles and Lessons Learned from Applications in the Treatment of Metastatic Prostate Cancer. Recent Results in Cancer Research, 180, 165-183.
https://doi.org/10.1007/978-3-540-78281-0_10
|
[43]
|
Kamen, B.A. (2005) Metronomic Therapy: It Makes Sense and Is Patient Friendly. Journal of Pediatric Hematology/Oncology, 27, 571-572.
https://doi.org/10.1097/01.mph.0000192148.90120.15
|
[44]
|
Sobrero, A.F., Aschele, C. and Bertino, J.R. (1997) Fluorouracil in Colorectal Cancer—A Tale of Two Drugs: Implications for Biochemical Modulation. Journal of Clinical Oncology, 15, 368-381.
|
[45]
|
Takahashi, Y., Mai, M., Sawabu, N. and Nishioka, K. (2005) A Pilot Study of Individualized Maximum Repeatable Dose (iMRD), a New Dose Finding System, of Weekly Gemcitabine for Patients with Metastatic Pancreas Cancer. Pancreas, 30, 206-210. https://doi.org/10.1097/01.mpa.0000153335.73352.c7
|
[46]
|
Pasquier, E., Kavallaris, M. and Andre, N. (2010) Metromic Chemotherapy: New Rationale for New Directions. Nature Reviews Clinical Oncology, 7, 455-465.
https://doi.org/10.1038/nrclinonc.2010.82
|
[47]
|
Labrinidis, A., Hay, S., Lipis, V., Findlay, D.M. and Evdokiou, A. (2010) Zoledronic Acid Protects Against Osteosarcoma-Induced Bone Destruction but Lacks Efficacy against Pulmonary Metastases in a Syngeneic Rat Model. International Journal of Cancer, 127, 345-354. https://doi.org/10.1002/ijc.25051
|
[48]
|
Ottewell, P.D., Woodward, J.K., Lefley, D.V., Evans, C.A., Coleman, R.E. and Holen, I. (2009) Anticancer Mechanisms of Doxorubicin and Zoledronic Acid in Breast Cancer Tumor Growth in Bone. Molecular Cancer Therapeutics, 8, 2821-2832. https://doi.org/10.1158/1535-7163.MCT-09-0462
|
[49]
|
Thangapazham, R.L., Passi, N. and Maheshwari, R.K. (2007) Green Tea Polyphenol and Epigallocatechin Gallate Induce Apoptosis and Inhibit Invasion in Human Breast Cancer Cells. Cancer Biology & Therapy, 6, 1938-1943.
https://doi.org/10.4161/cbt.6.12.4974
|
[50]
|
Luo, K.W., Ko, C.H., Yue, G.G., Lee, J.K., Li, K.K., Lee, M., et al. (2014) Green Tea (Camellia sinensis) Extract Inhibits Both the Metastasis and Osteolytic Components of Mammary Cancer 4T1 Lesions in Mice. The Journal of Nutritional Biochemistry, 25, 395-403. https://doi.org/10.1016/j.jnutbio.2013.11.013
|
[51]
|
Luo, K.W., Ko, C.H., Yue, G.G., Gao, S., Lee, J.K., Li, G., et al. (2015) The Combined Use of Camellia sinensis and Metronomic Zoledronic Acid in a Breast Cancer-Induced Osteolysis Mouse Model. Journal of Cancer Research and Clinical Oncology, 141, 1025-1036. https://doi.org/10.1007/s00432-014-1882-1
|
[52]
|
Luo, K.W., Yue, G.G., Ko, C.H., Lee, J.K., Gao, S., Li, L.F., et al. (2014) In Vivo and in Vitro Anti-Tumor and Anti-Metastasis Effects of Coriolus Versicolor Aqueous Extract on Mouse Mammary 4T1 Carcinoma. Phytomedicine, 21, 1078-1087.
https://doi.org/10.1016/j.phymed.2014.04.020
|
[53]
|
Wong, E., Cheng, K.F. and Leung, P.C. (2012) Efficacy of Yunzhi (Trametes versicolor) on Survival in Cancer Patients: Systematic Review and Meta-Analysis. Recent Patents on Inflammation & Allergy Drug Discovery, 6, 78-87.
https://doi.org/10.2174/187221312798889310
|
[54]
|
Luo, K.W., Ko, C.H., Yue, G.G., Lee, M.Y., Siu, W.S., Lee, J.K., et al. (2013) Anti-Tumor and Anti-Osteolysis Effects of the Metronomic Use of Zoledronic Acid in Primary and Metastatic Breast Cancer Mouse Models. Cancer Letters, 339, 42-48.
https://doi.org/10.1016/j.canlet.2013.07.024
|
[55]
|
Zhao, X., Xu, X., Guo, L., Ragaz, J, Guo, H., Wu, J., et al. (2010) Biomarker Alterations with Metronomic Use of Low-Dose Zoledronic Acid for Breast Cancer Patients with Bone Metastases and Potential Clinical Significance. Breast Cancer Res Treat, 124, 733-743. https://doi.org/10.1007/s10549-010-1183-6
|
[56]
|
Lien, K., Georgsdottir, S., Sivanathan, L., Chan, K. and Emmenegger, U. (2013) Low-Dose Metronomic Chemotherapy: A Systematic Literature Analysis. European Journal of Cancer, 49, 3387-3395. https://doi.org/10.1016/j.ejca.2013.06.038
|
[57]
|
Noronha, V., Krishna, M.V., Patil, V., Joshi, A., Banavali, S.D. and Prabhash, K. (2013) Metronomic Therapy: Chemotherapy Revisited. Indian Journal of Cancer, 50, 142-148. https://doi.org/10.4103/0019-509X.117027
|